「by」の検索結果
77件：6～10件目を表示
-
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
Enhancement of therapeutic efficacy of Brinzolamide for Glaucoma by nanocrystallization and tyloxapol addition Shuya Masuda 1,2, Shiho Yano 1, Tomohisa Tadokoro 1, Hiroko Otake 1, Noriaki Nagai 1 1 Fa...
https://www.senju.co.jp/rd/thesis/ -
ルミガン点眼液0.03％
ラリアの分類：An Australian categorisation of risk of drug use in pregnancy B３：Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the...
https://www.senju.co.jp/sites/default/files/2020-09/RM_IF.pdf -
ical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has started Phase III clinical trials in Japan for an in-house developed compou...
https://www.senju.co.jp/sites/default/files/content_news/2024-05/ENG_20240509_0.pdf -
发表论文 | 研究与开发 | 千寿制药株式会社
Enhancement of therapeutic efficacy of Brinzolamide for Glaucoma by nanocrystallization and tyloxapol addition Shuya Masuda 1,2, Shiho Yano 1, Tomohisa Tadokoro 1, Hiroko Otake 1, Noriaki Nagai 1 1 Fa...
http://www.senju.co.jp/chinese/rd/thesis/ -
Production | About Senju | SENJU Pharmaceutical
quality, compliance, and supply using the latest equipment and ensure a better working environment by following excellent hygiene control. Pharmaceutical products, the life of SENJU Pharmaceutical, a...
https://www.senju.co.jp/english/about/production.html